NCT03222817View on ClinicalTrials.gov

HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 12, 2018

Primary Completion Date

October 17, 2018

Study Completion Date

October 17, 2018

Conditions
Cervical Cancer Screening
Interventions
BEHAVIORAL

HPV self-sampling

Participants will be provided with education regarding cervical cancer screening, as well as instructions regarding how to use the HPV self-sampler. Participants will also receive referrals to trans-competent healthcare providers for follow-up screening and care.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT03222817 - HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals | Biotech Hunter | Biotech Hunter